Low density lipoprotein epidemiology and demographics: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 18: | Line 18: | ||
Shown below is a diagram depicting the age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.) | Shown below is a diagram depicting the age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.) | ||
[[ | [[File:Use of LDL lowering drugs.gif|Age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010]] | ||
Shown below an image depicting the age-adjusted trends in prevalence of high LDL cholesterol, use of cholesterol-lowering medications, and low saturated-fat intake among adults aged 40–74 in the United States between 1976–1980 and 2007–2010. | Shown below an image depicting the age-adjusted trends in prevalence of high LDL cholesterol, use of cholesterol-lowering medications, and low saturated-fat intake among adults aged 40–74 in the United States between 1976–1980 and 2007–2010. | ||
[[File: | [[File:Trends in prevalence of high LDL cholesterol, use of cholesterol-lowering medications, and low saturated-fat intake in the United States.png|300px]] | ||
<span style="font-size:80%"> | |||
<sup>1</sup> Significant decreasing linear trends from 1976–1980 to 2007–2010 (p < 0.05).<br> | |||
<sup>2</sup> Significant increase from 1976–1980 to 1988–1994 (p < 0.05); no significant change from 1988–1994 to 2007–2010.<br> | |||
<sup>3</sup> Significant increasing trend from 1988–1994 to 2007–2010. | |||
</span> | |||
===Gender=== | ===Gender=== | ||
Revision as of 14:07, 27 September 2014
|
Low Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Low density lipoprotein epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Low density lipoprotein epidemiology and demographics |
|
FDA on Low density lipoprotein epidemiology and demographics |
|
CDC on Low density lipoprotein epidemiology and demographics |
|
Low density lipoprotein epidemiology and demographics in the news |
|
Blogs on Low density lipoprotein epidemiology and demographics |
|
Risk calculators and risk factors for Low density lipoprotein epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
From 1976–1980 through 2007–2010, for U.S. adults aged 40–74, a decrease was observed in the prevalence of high LDL-cholesterol (LDL–C) from 59% to 28%, as well as an increase in adults using lipid-lowering medications and consuming a diet low in saturated fat. Despite recent advances in medical treatment, high LDL-C remains a significant public health problem in the United States, with more than one-quarter of adults aged 40–74 having high LDL–C.[1]
Epidemiology and Demographics
Prevalence
Overall, the prevalence of high LDL–C significantly decreased from 59% in 1976–1980 to 42% in 1988–1994, and to 33% in 2001–2004, reaching 27% in 2007–2010.[1]
The decrease in the prevalence of high LDL is paralleled by an increase in the use of cholesterol-lowering medication that grew from 5% in 1988–1994 to 17% in 2001–2004, and reached 23% in 2007–2010. In addition, the percentage of adults meeting guidelines for low saturated-fat intake increased significantly from 1976–1980 to 1988–1994, from 25% to 41%, but no significant change occurred from 1988–1994 through 2007–2010.[1]
Shown below is a diagram depicting the age-adjusted prevalence of high LDL cholesterol among adults aged 40–74, by sex and age in the United States between 1976–1980 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.)
Shown below is a diagram depicting the age adjusted use of cholesterol-lowering medications among adults aged 40–74 in the United States between 1988–1994 and 2007–2010. (Source: CDC/NCHS, National Health and Nutrition Examination Survey.)
Shown below an image depicting the age-adjusted trends in prevalence of high LDL cholesterol, use of cholesterol-lowering medications, and low saturated-fat intake among adults aged 40–74 in the United States between 1976–1980 and 2007–2010.
1 Significant decreasing linear trends from 1976–1980 to 2007–2010 (p < 0.05).
2 Significant increase from 1976–1980 to 1988–1994 (p < 0.05); no significant change from 1988–1994 to 2007–2010.
3 Significant increasing trend from 1988–1994 to 2007–2010.
Gender
Between 1976–1980 and 2007–2010, the prevalence of high LDL–C significantly decreased for men from 65% to 31%.
The prevalence of high LDL–C also significantly decreased for and women from 54% to 24% between 1976–1980 and 2007–2010.[1]
Age
Between 1976–1980 and 2007–2010, the prevalence of high LDL–C significantly decreased for adults aged 40–64 (56% to 27%) and 65–74 (72% to 30%).[1]